|
LONRF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.60009999999567E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.939060E-03 |
| Normal-vs-Stage2 |
2.221800E-03 |
| Normal-vs-Stage3 |
1.337720E-03 |
| Normal-vs-Stage4 |
1.36819999996263E-06 |
| Stage1-vs-Stage2 |
6.749600E-01 |
| Stage1-vs-Stage3 |
5.468000E-01 |
| Stage1-vs-Stage4 |
2.40749999999013E-05 |
| Stage2-vs-Stage3 |
9.182600E-01 |
| Stage2-vs-Stage4 |
1.457530E-02 |
| Stage3-vs-Stage4 |
1.142020E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.776300E-04 |
| Normal-vs-AfricanAmerican |
6.419300E-04 |
| Normal-vs-Asian |
2.21400000000038E-05 |
| Caucasian-vs-AfricanAmerican |
3.534400E-01 |
| Caucasian-vs-Asian |
9.880000E-03 |
| AfricanAmerican-vs-Asian |
1.987750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.7190999999941E-05 |
| Normal-vs-Female |
2.336400E-03 |
| Male-vs-Female |
5.056800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.716500E-03 |
| Normal-vs-Extreme_Weight |
8.376200E-03 |
| Normal-vs-Obese |
1.657550E-03 |
| Normal-vs-Extreme_Obese |
2.243100E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.706400E-01 |
| Normal_Weight-vs-Obese |
8.425600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.499000E-01 |
| Extreme_Weight-vs-Obese |
7.129000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.059800E-01 |
| Obese-vs-Extreme_Obese |
7.137200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.535170E-01 |
| Normal-vs-Age(41-60Yrs) |
4.318000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.955650E-04 |
| Normal-vs-Age(81-100Yrs) |
5.659700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.083400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.865790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.974200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.015980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.789800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.022800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.232600E-04 |
| Normal-VS-Type2 PRCC |
2.40129999999894E-05 |
| Normal-VS-KIRP CIMP |
6.013400E-01 |
| Normal-VS-Unclassified PRCC |
1.838560E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.576200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.671600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.923600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.054400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.018600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.211900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.2925000000027E-05 |
| Normal-vs-N1 |
5.661200E-03 |
| Normal-vs-N2 |
4.755200E-01 |
| N0-vs-N1 |
8.283700E-02 |
| N0-vs-N2 |
4.666600E-01 |
| N1-vs-N2 |
5.290200E-01 |
|
|
